Advertisement

Related Videos

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Deborah Collyar: What's In It for Patients?

Welcome and Introduction to Vi3C

Advertisement

Advertisement




Feb
17
Today In Oncology
Oxybutynin May Improve ADT-Induced Hot Flashes in Patients With Prostate Cancer
Determining the Optimal Duration of Androgen-Deprivation Therapy Added to Definitive Radiotherapy in Localized Prostate Cancer
Induction Nivolumab Before CRT in High-Risk HPV-Driven OPC
Neoadjuvant Taxane Plus Trastuzumab and Pertuzumab With or Without Carboplatin in HER2-Positive Breast Cancer
Nonmetastatic Breast Cancer Treatment Strategies After Denosumab Discontinuation in Patients Treated With Aromatase Inhibitors
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo